This is not surprising given that PRMT5 over-expression has recently been identified in lung carcinoma, glioblastoma, B-cell lymphoma, mantle cell lymphoma, and melanoma, to name just a few [28,31,48,49,50]. This evidence concerns the gene PRMT5 and glioblastoma.